Hims & Hers Investors Sue Over Securities Fraud
Investors in Hims & Hers Health, Inc. have been notified of an opportunity to lead a securities fraud lawsuit. The lawsuit targets alleged misrepresentations made between August 4, 2025, and July 29, 2026.
Rosen Law Firm has announced that investors who purchased securities in Hims & Hers Health, Inc. (NYSE: HIMS) during the class period of August 4, 2025, to July 29, 2026, may have the opportunity to serve as lead plaintiff in a securities fraud lawsuit.
The law firm, specializing in investor rights, is seeking investors to come forward by November 2, 2026, for this legal action. The lawsuit alleges that the company and certain executives made false and misleading statements regarding its business operations and prospects during the specified period.
Specifically, the claims revolve around alleged misrepresentations concerning the company's financial performance and the sustainability of its growth strategies. Investors are advised that the lead plaintiff designation is a crucial step in securities litigation.
Rosen Law Firm has a history of representing investors in class action lawsuits. The firm encourages shareholders who believe they have suffered losses due to these alleged misrepresentations to contact them for more information regarding their rights and the potential lead plaintiff process.